Oct. 28, 2024 — Medtronic, a global leader in medical technology, today announced the appointment of Dr. Matthew Kroh as the Chief Medical Officer (CMO) for Advanced Surgical Technologies and General Surgical Technologies, underscoring the company’s commitment to advancing surgical innovation and improving patient outcomes.

A board-certified general surgeon with fellowship training in advanced laparoscopic and bariatric surgery and surgical endoscopy, Dr. Kroh brings extensive clinical and healthcare leadership experience to Medtronic, guiding the new product development and commercialization strategies within the Surgical business. Under his leadership, Medtronic aims to deepen its clinical insights and enhance its engagement with physicians and medical societies globally.

"We are excited to welcome Dr. Kroh to Medtronic and to add his expertise, passion, and innovative spirit to our business," said Justin Roberts, general manager and vice president of Advanced Surgical Technologies within the Surgical business, part of the Medical Surgical Portfolio at Medtronic. "His experience in pioneering surgical innovation will be invaluable as we continue to push the boundaries of what's possible in medical technology."

Dr. Kroh, currently Division Chief for Foregut and Surgical Endoscopy at the Cleveland Clinic, is a respected leader in surgical research and innovation with vast experience in early-phase clinical trials and various contributions to the development of minimally invasive surgical techniques, including robotics and single-incision laparoscopic surgery. Dr. Kroh is a member of several esteemed scientific committees and has authored over 175 peer-reviewed articles.

"I am honored to join Medtronic, a company renowned for its dedication to transforming healthcare through innovation," stated Dr. Kroh. "I look forward to contributing to the development of surgical technologies that can broaden access and improve outcomes for patients worldwide."

In his new role, Dr. Kroh will continue to practice surgery at the Cleveland Clinic, ensuring he remains at the forefront of clinical practice and innovation.

This appointment emphasizes the company’s strategy of combining top medical expertise with cutting-edge innovation in addressing the changing needs of both clinicians and patients.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts: 
Martha Acevedo
Public Relations
+1-786-574-0493

Ryan Weispfenning
Investor Relations
+1-763-505-4626